scholarly article | Q13442814 |
P356 | DOI | 10.1007/S004320050009 |
P698 | PubMed publication ID | 10641751 |
P2093 | author name string | J Zhou | |
F Liu | |||
J Fan | |||
Z Y Tang | |||
X M Li | |||
Y K Liu | |||
Z Q Wu | |||
H C Sun | |||
S L Ye | |||
P433 | issue | 1 | |
P921 | main subject | cell growth | Q189159 |
hepatocellular carcinoma | Q1148337 | ||
P304 | page(s) | 57-61 | |
P577 | publication date | 2000-01-01 | |
P1433 | published in | Journal of Cancer Research and Clinical Oncology | Q2081599 |
P1476 | title | Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus | |
P478 | volume | 126 |
Q35611503 | A decade's studies on metastasis of hepatocellular carcinoma |
Q35701281 | Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives |
Q41947562 | Angiogenesis in rabbit hepatic tumor after transcatheter arterial embolization |
Q44269246 | Clinical characteristics and survival of European patients with resectable large hepatocellular carcinomas |
Q35165648 | Clinical significance of angiogenesis in gastrointestinal cancers: a target for novel prognostic and therapeutic approaches |
Q34382605 | Clinical significance of the expression of isoform 165 vascular endothelial growth factor mRNA in noncancerous liver remnants of patients with hepatocellular carcinoma |
Q35010945 | Construction and clinical significance of a predictive system for prognosis of hepatocellular carcinoma |
Q34452728 | Experimental study on enhancement of the metastatic potential of portal vein tumor thrombus-originated hepatocellular carcinoma cells using portal vein serum |
Q36190339 | Expression of MUC1 and its significance in hepatocellular and cholangiocarcinoma tissue |
Q44606862 | Expression of angiogenic factors in hepatocellular carcinoma after transcatheter arterial chemoembolization |
Q35698574 | HCC and angiogenesis: possible targets and future directions |
Q33695543 | Hedgehog inhibition reduces angiogenesis by downregulation of tumoral VEGF-A expression in hepatocellular carcinoma |
Q35642468 | Hepatic stellate cells: central modulators of hepatic carcinogenesis |
Q33410073 | Hepatocellular carcinoma size: platelets, γ-glutamyl transpeptidase, and alkaline phosphatase |
Q34512068 | Hepatocellular carcinoma--cause, treatment and metastasis |
Q45924805 | High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection. |
Q44193693 | High vascular endothelial growth factor (VEGF) expression in chemically-induced hepatic microcancers in mice |
Q33416414 | Identification of two clinical hepatocellular carcinoma patient phenotypes from results of standard screening parameters |
Q34457421 | Inhibition of vascular endothelial growth factor in the treatment of solid tumors |
Q40468150 | Interferon alpha 2a down-regulates VEGF expression through PI3 kinase and MAP kinase signaling pathways. |
Q44835572 | Interferon-alpha 2a up-regulated thymidine phosphorylase and enhanced antitumor effect of capecitabine on hepatocellular carcinoma in nude mice |
Q36474130 | Is the vascular endothelial growth factor messenger RNA expression in resectable hepatocellular carcinoma of prognostic value after resection? |
Q36917485 | Linking molecular classification of hepatocellular carcinoma and personalized medicine: preliminary steps. |
Q92527657 | Macrophage-specific hypoxia-inducible factor-1α deletion suppresses the development of liver tumors in high-fat diet-fed obese and diabetic mice |
Q48355658 | Mechanism of interferon alpha on inhibition of metastasis and angiogenesis of hepatocellular carcinoma after curative resection in nude mice |
Q33412956 | Platelet extracts induce growth, migration and invasion in human hepatocellular carcinoma in vitro |
Q36474101 | Prognostic significance of preoperative circulating vascular endothelial growth factor messenger RNA expression in resectable hepatocellular carcinoma: a prospective study |
Q80059478 | Relationship between the changes of VEGF level and dendritic cells in peripheral blood of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization |
Q45871475 | Risk factors of poor prognosis and portal vein tumor thrombosis after curative resection of solitary hepatocellular carcinoma |
Q60915777 | Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy |
Q34668320 | The prognostic molecular markers in hepatocellular carcinoma |
Q37773788 | The role of signaling pathways in the development and treatment of hepatocellular carcinoma |
Q33405280 | Thrombocytosis and hepatocellular carcinoma |
Search more.